ARCHIVES

Taxol Approved By FDA For Ovarian Cancer; Bristol Sets Price Tier In Line With Platinum

This article is from The Cancer Letter archive.

Vol. 19 No. 02 | January 8, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: Upton Still Pondering Location Of Centers, Other Program; Moves Could Involve DCCR

April 27, 1979

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

FASEB Says NIH Budge Should Reach $10 Bil. In Fiscal 1993

January 10, 1992

Program Project Payline Is 125; Budget Cuts Will Allow NCI To Fund 49 Competing P01s

February 28, 1992

FDA Orders More Changes In ESA Label,

August 8, 2008

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013